Rowley Law PLLC is investigating potential claims against Loxo Oncology, Inc. and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Eli Lilly and Company
NEW YORK, Jan. 7, 2019 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Loxo Oncology, Inc. (NASDAQ: LOXO) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Eli Lilly and Company (NYSE: LLY). Stockholders will receive $235.00 for each share of Loxo Oncology, Inc. stock that they hold. The transaction is valued at approximately $8 billion and is expected to close by the end of the first quarter of 2019.
If you are a stockholder of Loxo Oncology, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/loxo. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-loxo-oncology-inc-300774258.html
SOURCE Rowley Law PLLC
Company Codes: NASDAQ-NMS:LOXO, NYSE:LLY
